News


Viamet Appoints Dr. Oren Cohen as Chief Medical Officer

Experienced Pharmaceutical Executive and Leading Expert in Clinical Development

Viamet Pharmaceuticals, Inc. today announced the appointment of Oren Cohen, M.D., as Chief Medical Officer to further strengthen the company’s management team. Dr. Cohen is a leading authority on the development of drugs for the treatment of infectious diseases and multiple other indications. Prior to joining Viamet, Dr. Cohen served as Senior Vice President and Global Head, Early Clinical Development as well as Chief Medical Officer for Quintiles Inc., where he was involved in the oversight of over 200 industry-sponsored clinical trials across numerous therapeutic areas.

“Oren’s clinical development expertise will be a key asset as we transition to a clinical-stage company with multiple product candidates,” commented Robert Schotzinger, MD, PhD, CEO of Viamet. “We are thrilled to have Oren join our management team and help us advance our portfolio of breakthrough drug candidates to treat both chronic and life-threatening fungal infections, cancer and orphan diseases.”